Weekly CEO Buys Highlight

Details the CEO buys this past week for the following companies: American Assets Trust, OPKO Health, Quidel, Cannae Holdings and Conduent

Author's Avatar
Mar 01, 2021
Article's Main Image

According to GuruFocus Insider Data, these were the largest CEO buys during the past week.

American Assets Trust

American Assets Trust Inc. (AAT, Financial) Chairman, CEO, President and 10% Owner Ernest S. Rady bought 117,998 shares on Feb. 22 at a price of $29.50. The price of the stock has increased by 5.36% since then.

2086389682.jpg

American Assets Trust is a self-administered real estate investment trust based in the United States. The company invests in, operates and develops retail, office, residential and mixed-use properties primarily located in California, Oregon, Washington and Hawaii.

The company has a market cap of $1.88 billion. Its shares traded at $31.08 with a price-earnings ratio of 67.27 as of Feb. 26.

Net income was $2.9 million for the fourth quarter of 2020 compared to $12.8 million for the comparable period of 2019.

OPKO Health

OPKO Health Inc. (OPK, Financial) CEO, Chairman and 10% Owner Phillip Frost bought 500,000 shares on Feb. 19 at a price of $4.77. Since then, the price of the stock has decreased by 5.66%.

2017807208.jpg

OPKO Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. OPKO's diagnostics business includes a core genetic testing operation.

The company has a market cap of $3.02 billion. Its shares traded at $4.50 with a price-earnings ratio of 93.75 as of Feb. 26.

Net income for the fourth quarter of 2020 was $32.3 million compared with a net loss of $112.4 million for the comparable period of 2019.

Quidel

Quidel Corp. (QDEL, Financial) President and CEO Douglas C. Bryant bought 5,000 shares on Feb. 22 at a price of $165.30. The price of the stock has decreased by 0.63% since then.

96721977.jpg

Quidel is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions.

The company has a market cap of $6.95 billion. Its shares traded at $164.26 with a price-earnings ratio of 8.83 as of Feb. 26.

Net income for the fourth quarter of 2020 was $470.1 million as compared to a net income of $30.6 million for the fourth quarter of 2019.

Senior Vice President, Research & Development Werner Kroll sold 22,902 shares on Feb. 24 at a price of $166.79. Since then, the price of the stock has decreased by 1.52%.

Cannae Holdings

Cannae Holdings Inc. (CNNE, Financial) CEO Richard N. Massey bought 10,000 shares on Feb. 24 at a price of $39.78. The price of the stock has decreased by 6.11% since then.

2059937672.jpg

Cannae Holdings is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant group, Ceridian, T-System, Dun & Bradstreet, Corporate and other.

The company has a market cap of $3.42 billion. Its shares traded at $37.35 with a price-earnings ratio of 1.80 as of Feb. 26.

Net earnings for the fourth quarter of 2020 were $531.3 million compared to $24.5 million for the prior-year period.

Conduent

CEO of Conduent Inc. (CNDT, Financial) Clifford Skelton bought 20,661 shares on Feb. 22 at a price of $4.85. Since then, the price of the stock has increased by 10.93%.

251538273.jpg

Conduent acts as a multinational provider of business process services with expertise in transaction-intensive processing, analytics and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as multi-industry services such as transaction processing, customer care and payment services.

The company has a market cap of $1.14 billion. Its shares traded at $5.38 as of Feb. 26.

Net loss for the fourth quarter of 2020 was $11 million compared to a loss of $581 million for the prior-year quarter.

Director A. Scott Letier bought 10,000 shares on Feb. 22 at a price of $4.95. The price of the stock has increased by 8.69% since then.

Executive Vice President and Chief Information Officer Mark Prout bought 3,000 shares on Feb. 22 at a price of $4.88. Since then, the price of the stock has increased by 10.25%.

For the complete list of stocks bought by their company CEOs, go to: CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.